Al-Azhar university
Asyut, Egypt
NCT Number: NCT06654778
the aim of this prospective randomized blinded clinical study will be to assess the ultrasound evaluation of different preventive measures of post operative lung atelectasis in abdominal surgeries; these measures include ventilation and fluid measures
Looking for future studies?
Notify Me30 year–60 year
All sexes
Interventional
Not applicable
Asyut, Egypt
ultrasound evaluation for application of different preventive measures of post operative lung atelectasis, including positive end-expiratory pressure, lung recruitment maneuvers, and restrictive fluid management.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will be ventilated with PEEP of 8 cm H2O and fluid management: 500 ml of Ringer's lactate in the recovery room before surgery and Ringer's lactate at a rate of 4 mL/kg/hour from the beginning to the end of the surgery.
Patients will be ventilated with PEEP of 8 cm H2O, and then RM (30 cm H2O for 30 s) will be applied immediately after the second LUS examination and repeated every 30 minutes till emergence and fluid management: 500 ml of Ringer's lactate in recovery room before surgery and Ringer's lactate at a rate of 4 mL/kg/hour from the beginning to the end of the surgery
Patients will be ventilated with PEEP of 8 cm H2O, and then RM (30 cm H2O for 30 s) will be applied immediately after the second LUS examination and repeated every 30 minutes till emergence and restrictive fluid management (RF). Ringer's lactate at a rate of 3 mL/kg/hour from the beginning to the end of the surgery
Time frame: at the end of surgery before emergence from GA.
Lung ultrasound assessment of postoperative pulmonary atelectasis at the end of surgery.
The Lung Ultrasound Score (LUS): the key points based on ultrasound findings:
I. 0 points: (N) Normal aeration (presence of lung sliding with A-lines or <2 separate B-lines).
II. 1 point: (B1) Moderate loss of lung aeration (≥3 well-defined B lines). III. 2 points: (B2) Severe loss of lung aeration (coalescing B-lines). IV. 3 points: (C) Complete loss of lung aeration (pulmonary consolidations). Total Score: points will be distributed according to the worst ultrasound pattern observed: N = 0, B1 lines = 1, B2 lines = 2, C = 3. The LUS score ranging between 0 and 36 was calculated as the sum of points.
Time frame: before induction of general anesthesia
Lung ultrasound assessment of atelectasis
Time frame: 5 minutes post induction of general anesthesia
Lung ultrasound assessment of atelectasis
Time frame: 15 minutes after patients arrive to PACU
Lung ultrasound assessment of atelectasis
Time frame: 60 minutes after patients arrive to PACU
Lung ultrasound assessment of atelectasis
Time frame: 5 minutes post induction of general anesthesia
Pao2, spo2, paco2, pao2/fio2
Time frame: before emergence from general anesthesia
Pao2, spo2, paco2, pao2/fio2
Time frame: 15 minutes after patients arrive to PACU
Pao2, spo2, paco2, pao2/fio2
Al-Azhar University
Other
Ultrasound Evaluation of Different Preventive Measures of Post Operative Lung Atelectasis After Upper Abdominal Surgeries: Ventilation and Fluid Measures
Acronym: LUS/PEEP/RM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07680881
Lung Diseases, Postoperative Pulmonary Complications
Istanbul, Sisli, Turkey (Türkiye)
View Trial DetailsNCT06746181
Lung Diseases, Pulmonary Atelectasis
Yangzhou, Jiangsu, China
View Trial DetailsNCT04085146
Lung Diseases, Pulmonary Atelectasis
Seoul, South Korea
View Trial DetailsNCT03486847
Atelectasis, Compression, Lung Diseases
Seoul, Jongnogu, South Korea
View Trial Details